{"entity":{"type":"insider","cik":"0001746251","url":"/insider/0001746251","json_url":"/insider/0001746251.json","name":"Dreyer Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":23,"first":"2019-07-12","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Dreyer Scott","source":"filing","n_filings":23,"first_seen":"2019-07-12","last_seen":"2026-03-05"}],"transactions":[{"id":5949425,"accession":"0001746251-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001746251-26-000004","line_url":"/filing/0001746251-26-000004","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49976.0,"shares_display":"49,976","price_per_share":40.408130228509684,"price_display":"40.41","price_state":"stated","total_value":2019436.7163,"total_display":"2,019,436.72","total_whole":"2,019,437","shares_owned_after":75329.0,"shares_owned_after_display":"75,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider","n_lines":2},{"id":4185826,"accession":"0001746251-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001746251-25-000004","line_url":"/filing/0001746251-25-000004","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17600.0,"shares_display":"17,600","price_per_share":48.173590625,"price_display":"48.17","price_state":"stated","total_value":847855.195,"total_display":"847,855.20","total_whole":"847,855","shares_owned_after":110088.0,"shares_owned_after_display":"110,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":4029204,"accession":"0001062993-25-014766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-014766","line_url":"/filing/0001062993-25-014766#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16389.0,"shares_display":"16,389","price_per_share":38.2068,"price_display":"38.21","price_state":"stated","total_value":626171.2452,"total_display":"626,171.25","total_whole":"626,171","shares_owned_after":103613.0,"shares_owned_after_display":"103,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4798568,"accession":"0001062993-25-014526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-014526","line_url":"/filing/0001062993-25-014526#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4861.0,"shares_display":"4,861","price_per_share":38.0335,"price_display":"38.03","price_state":"stated","total_value":184880.8435,"total_display":"184,880.84","total_whole":"184,881","shares_owned_after":103613.0,"shares_owned_after_display":"103,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":4420733,"accession":"0001062993-25-006148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-006148","line_url":"/filing/0001062993-25-006148#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18881.0,"shares_display":"18,881","price_per_share":30.0293,"price_display":"30.03","price_state":"stated","total_value":566983.2133,"total_display":"566,983.21","total_whole":"566,983","shares_owned_after":103613.0,"shares_owned_after_display":"103,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4420727,"accession":"0001062993-25-006148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-006148","line_url":"/filing/0001062993-25-006148#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1927.0,"shares_display":"1,927","price_per_share":30.0005,"price_display":"30.00","price_state":"stated","total_value":57810.9635,"total_display":"57,810.96","total_whole":"57,811","shares_owned_after":122494.0,"shares_owned_after_display":"122,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":4508522,"accession":"0001062993-25-005752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005752","line_url":"/filing/0001062993-25-005752#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2255.0,"shares_display":"2,255","price_per_share":30.0049,"price_display":"30.00","price_state":"stated","total_value":67661.0495,"total_display":"67,661.05","total_whole":"67,661","shares_owned_after":124421.0,"shares_owned_after_display":"124,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":9219307,"accession":"0001062993-25-005834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005834","line_url":"/filing/0001062993-25-005834#line-1","is_derivative":false,"issuer_cik":"0001746251","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001746251","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15387.0,"shares_display":"15,387","price_per_share":30.004,"price_display":"30.00","price_state":"stated","total_value":461671.548,"total_display":"461,671.55","total_whole":"461,672","shares_owned_after":126676.0,"shares_owned_after_display":"126,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-18","scope":"insider"},{"id":5160683,"accession":"0001062993-25-005020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-005020","line_url":"/filing/0001062993-25-005020#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2348.0,"shares_display":"2,348","price_per_share":30.0025,"price_display":"30.00","price_state":"stated","total_value":70445.87,"total_display":"70,445.87","total_whole":"70,446","shares_owned_after":142063.0,"shares_owned_after_display":"142,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-10","scope":"insider"},{"id":5160680,"accession":"0001062993-25-005020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005020","line_url":"/filing/0001062993-25-005020#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3295.0,"shares_display":"3,295","price_per_share":30.0011,"price_display":"30.00","price_state":"stated","total_value":98853.6245,"total_display":"98,853.62","total_whole":"98,854","shares_owned_after":144411.0,"shares_owned_after_display":"144,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-10","scope":"insider"},{"id":5077576,"accession":"0001062993-25-005396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-005396","line_url":"/filing/0001062993-25-005396#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15387.0,"shares_display":"15,387","price_per_share":30.004,"price_display":"30.00","price_state":"stated","total_value":461671.548,"total_display":"461,671.55","total_whole":"461,672","shares_owned_after":126676.0,"shares_owned_after_display":"126,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-13","scope":"insider"},{"id":2960843,"accession":"0001062993-24-011338","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-24-011338","line_url":"/filing/0001062993-24-011338#line-4","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56807.0,"shares_display":"56,807","price_per_share":33.9827,"price_display":"33.98","price_state":"stated","total_value":1930455.2389,"total_display":"1,930,455.24","total_whole":"1,930,455","shares_owned_after":105902.0,"shares_owned_after_display":"105,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-24","filed_date":"2024-05-28","scope":"insider"},{"id":2960831,"accession":"0001062993-24-011338","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-011338","line_url":"/filing/0001062993-24-011338#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51209.0,"shares_display":"51,209","price_per_share":33.824,"price_display":"33.82","price_state":"stated","total_value":1732093.216,"total_display":"1,732,093.22","total_whole":"1,732,093","shares_owned_after":138918.0,"shares_owned_after_display":"138,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"},{"id":2553423,"accession":"0001062993-24-004754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-004754","line_url":"/filing/0001062993-24-004754","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":36.42703264,"price_display":"36.43","price_state":"stated","total_value":364270.3264,"total_display":"364,270.33","total_whole":"364,270","shares_owned_after":139582.0,"shares_owned_after_display":"139,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-28","scope":"insider","n_lines":2},{"id":2244751,"accession":"0001062993-24-001028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-001028","line_url":"/filing/0001062993-24-001028#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23560.0,"shares_display":"23,560","price_per_share":32.2801,"price_display":"32.28","price_state":"stated","total_value":760519.156,"total_display":"760,519.16","total_whole":"760,519","shares_owned_after":111322.0,"shares_owned_after_display":"111,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8696237,"accession":"0001062993-23-005854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-005854","line_url":"/filing/0001062993-23-005854#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13324.0,"shares_display":"13,324","price_per_share":26.7,"price_display":"26.70","price_state":"stated","total_value":355750.8,"total_display":"355,750.80","total_whole":"355,751","shares_owned_after":134882.0,"shares_owned_after_display":"134,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":8647097,"accession":"0001062993-23-000826","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-23-000826","line_url":"/filing/0001062993-23-000826","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17834.0,"shares_display":"17,834","price_per_share":27.39452562521027,"price_display":"27.39","price_state":"stated","total_value":488553.97,"total_display":"488,553.97","total_whole":"488,554","shares_owned_after":110208.0,"shares_owned_after_display":"110,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider","n_lines":3},{"id":6239132,"accession":"0001062993-22-005911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-005911","line_url":"/filing/0001062993-22-005911#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10559.0,"shares_display":"10,559","price_per_share":21.61,"price_display":"21.61","price_state":"stated","total_value":228179.99,"total_display":"228,179.99","total_whole":"228,180","shares_owned_after":121226.0,"shares_owned_after_display":"121,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-28","scope":"insider"},{"id":4158940,"accession":"0001879789-21-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001879789-21-000022","line_url":"/filing/0001879789-21-000022#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5693.0,"shares_display":"5,693","price_per_share":18.33,"price_display":"18.33","price_state":"stated","total_value":104352.69,"total_display":"104,352.69","total_whole":"104,353","shares_owned_after":76970.0,"shares_owned_after_display":"76,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":5284316,"accession":"0001192482-21-000151","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-21-000151","line_url":"/filing/0001192482-21-000151","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7898.0,"shares_display":"7,898","price_per_share":25.21300835654596,"price_display":"25.21","price_state":"stated","total_value":199132.34,"total_display":"199,132.34","total_whole":"199,132","shares_owned_after":83258.0,"shares_owned_after_display":"83,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-12","scope":"insider","n_lines":2},{"id":4551796,"accession":"0001192482-21-000063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-21-000063","line_url":"/filing/0001192482-21-000063#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1322.0,"shares_display":"1,322","price_per_share":22.89,"price_display":"22.89","price_state":"stated","total_value":30260.58,"total_display":"30,260.58","total_whole":"30,261","shares_owned_after":44395.0,"shares_owned_after_display":"44,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider"},{"id":2816924,"accession":"0001192482-20-000621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-20-000621","line_url":"/filing/0001192482-20-000621#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1429.0,"shares_display":"1,429","price_per_share":17.01,"price_display":"17.01","price_state":"stated","total_value":24307.29,"total_display":"24,307.29","total_whole":"24,307","shares_owned_after":46418.0,"shares_owned_after_display":"46,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":3085668,"accession":"0001192482-20-000350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-20-000350","line_url":"/filing/0001192482-20-000350#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":192000.0,"total_display":"192,000.00","total_whole":"192,000","shares_owned_after":48441.0,"shares_owned_after_display":"48,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2089085,"accession":"0001192482-20-000346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000346","line_url":"/filing/0001192482-20-000346#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4434.0,"shares_display":"4,434","price_per_share":22.61,"price_display":"22.61","price_state":"stated","total_value":100252.74,"total_display":"100,252.74","total_whole":"100,253","shares_owned_after":48441.0,"shares_owned_after_display":"48,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider"},{"id":3054859,"accession":"0001192482-20-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000038","line_url":"/filing/0001192482-20-000038#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1321.0,"shares_display":"1,321","price_per_share":23.87,"price_display":"23.87","price_state":"stated","total_value":31532.27,"total_display":"31,532.27","total_whole":"31,532","shares_owned_after":35716.0,"shares_owned_after_display":"35,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-14","filed_date":"2020-01-16","scope":"insider"},{"id":8484363,"accession":"0001192482-19-000312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-19-000312","line_url":"/filing/0001192482-19-000312#line-2","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001746251","owner_name":"Dreyer Scott","owner_display_name":"Dreyer Scott","owner_url":"/insider/0001746251","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":12.31,"price_display":"12.31","price_state":"stated","total_value":35169.67,"total_display":"35,169.67","total_whole":"35,170","shares_owned_after":37739.0,"shares_owned_after_display":"37,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Officer (EVP & Chief Commercial Officer)","n_filings":23,"first_seen":"2019-07-12","last_seen":"2026-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746251","retrieved_at":"2026-08-24T08:33:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}